The use of drug-eluting stents in everyday clinical practice: can the results of randomised trials be achieved in the "real world"?
Sionis
Dimitris G
DG
Haemodynamic Laboratory, Dept of Interventional Cardiology, 1st IKA Hospital, Athens, Greece. dsion@otenet.gr
D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation* / Q000379:methods; D020099:Coated Materials, Biocompatible; D023903:Coronary Restenosis / Q000453:epidemiology / Q000517:prevention & control*; D023921:Coronary Stenosis / Q000000981:diagnostic imaging / Q000401:mortality / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D017239:Paclitaxel / Q000494:pharmacology; D011237:Predictive Value of Tests; D011379:Prognosis; D011859:Radiography; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D020123:Sirolimus / Q000494:pharmacology; D015607:Stents; D016896:Treatment Outcome
D020099:Coated Materials, Biocompatible; D017239:Paclitaxel; D020123:Sirolimus